Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.

被引：0
|
作者：
Marcucci, G
Caligiuri, MA
Oberkircher, AR
Bloomfield, CD
机构：
[1] OHIO STATE UNIV,DIV HEMATOL ONCOL,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,ARTHUR G JAMES CANC HOSP,DIV HUMAN CANC GENET,COLUMBUS,OH 43210
[3] OHIO STATE UNIV,RES INST,COLUMBUS,OH 43210
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [31] PCR and RT-PCR based minimal residual disease (MRD) detection in long term follow up childhood acute lymphobalstic leukemia(ALL).
    Gameiro, P
    Papaioannou, M
    Moreira, I
    Yetgin, S
    Potter, MN
    Prentice, HG
    Mehta, AB
    Hoffbrand, AV
    Foroni, L
    BLOOD, 2001, 98 (11) : 318A - 318A
  • [32] POLYMERASE CHAIN-REACTION (PCR) APPROACH FOR THE EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
    BIONDI, A
    RAMBALDI, A
    STEM CELLS, 1994, 12 (04) : 394 - 401
  • [33] Use of the reverse transcription polymerase chain reaction (RT-PCR) for the rapid diagnosis of foot and mouth disease in South America
    Clavijo, A
    Viera-Pereira, PJ
    Bergmann, I
    VETERINARY RESEARCH COMMUNICATIONS, 2003, 27 (01) : 63 - 71
  • [34] Use of the Reverse Transcription Polymerase Chain Reaction (RT-PCR) for the Rapid Diagnosis of Foot and Mouth Disease in South America
    A. Clavijo
    P.J. Viera-Pereira
    I. Bergmann
    Veterinary Research Communications, 2003, 27 : 63 - 71
  • [35] Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
    G Marcucci
    KJ Livak
    W Bi
    MP Strout
    CD Bloomfield
    MA Caligiuri
    Leukemia, 1998, 12 : 1482 - 1489
  • [36] Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
    Marcucci, G
    Livak, KJ
    Bi, W
    Strout, MP
    Bloomfield, CD
    Caligiuri, MA
    LEUKEMIA, 1998, 12 (09) : 1482 - 1489
  • [37] Minimal residual disease (MRD) monitoring with qualitative RT-PCR in chronic myeloid leukemia (CML) patients submitted to allogeneic stem cell transplantation
    Bernasconi, P
    Alessandrino, EP
    Calatroni, S
    Caldera, D
    Colombo, AA
    Malcovati, L
    Varettoni, M
    Cavigliano, PM
    Rocca, B
    Boni, M
    Giardini, I
    Caresana, M
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S123 - S123
  • [38] Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia:: A multicenter study of 51 patients
    Morschhauser, F
    Cayuela, JM
    Martini, S
    Baruchel, A
    Rousselot, P
    Socié, G
    Berthou, P
    Jouet, JP
    Straetmans, N
    Sigaux, F
    Fenaux, P
    Preudhomme, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 788 - 794
  • [39] Feasibility and clinical significance of real time quantitative reverse transcription polymerase chain reaction (RT-PCR) assay in the study of PML-RARα fusion transcript in patients with acute promyelocytic leukemia.
    Gu, BW
    Hu, J
    Xu, L
    Yan, H
    Jin, WR
    Zhu, YM
    Zhao, WL
    Niu, C
    Cao, Q
    Su, XY
    Ying, HY
    Chen, Y
    Xiong, SM
    Shen, ZX
    Chen, Z
    Chen, SJ
    BLOOD, 2000, 96 (11) : 313A - 313A
  • [40] Predicting outcome of chronic myelogenous leukemia (CML) post allogeneic marrow transplantation by reverse transcription polymerase chain reaction (RT-PCR).
    Khouri, I
    Champlin, R
    Przepiorka, D
    Giralt, S
    Thall, P
    Kantarjian, H
    Cheng, SC
    Mirza, NQ
    Deisseroth, AB
    Lee, MS
    BLOOD, 1996, 88 (10) : 3802 - 3802
12345